{"id":2413,"date":"2025-04-18T13:02:18","date_gmt":"2025-04-18T04:02:18","guid":{"rendered":"https:\/\/www.japanmedia.co.jp\/?p=2413"},"modified":"2025-04-18T13:02:18","modified_gmt":"2025-04-18T04:02:18","slug":"nihon-media-co-ltd-and-aspark-mede-co-ltd","status":"publish","type":"post","link":"https:\/\/www.japanmedia.co.jp\/en\/topics\/%e6%97%a5%e6%9c%ac%e3%83%a1%e3%83%87%e3%82%a3%e3%82%a2%e6%a0%aa%e5%bc%8f%e4%bc%9a%e7%a4%be%e3%81%a8%e6%a0%aa%e5%bc%8f%e4%bc%9a%e7%a4%be%e3%82%a2%e3%82%b9%e3%83%91%e3%83%bc%e3%82%af%e3%83%a1%e3%83%87\/","title":{"rendered":"Japan Media Co., Ltd. and Aspark Medical, Inc. begin collaboration in data management and statistical analysis to accelerate contract research."},"content":{"rendered":"<span style=\"font-size: 14pt;\">Japan Media Co., Ltd. (Headquarters: Osaka City, Osaka Prefecture, Representative Director: Ryoji Kitamoto) has begun a collaboration with Aspark Medical Co., Ltd. (Headquarters: Osaka City, Osaka Prefecture, Representative Director: Tsunehiko Tatenai), a company specializing in human resource dispatch and pharmaceutical development support, in data management and statistical analysis operations, aiming to accelerate contract testing. In response to the current acceleration of pharmaceutical development, we will strive to contribute to pharmaceutical development by leveraging the synergistic effects of each company's strengths.<\/span>\r\n<h3><\/h3>\r\n&nbsp;\r\n<h3><span style=\"font-size: 14pt;\">About Japan Media Co., Ltd.<\/span><\/h3>\r\n<span style=\"font-size: 14pt;\">Japan Media Co., Ltd. is an IT company with extensive knowledge in the medical and healthcare fields and advanced SAS technical capabilities. Centered around the Life Science Business Division, the company contributes to the efficiency and speed of drug development by undertaking data management and statistical analysis services for the pharmaceutical and healthcare industries, as well as dispatching SAS engineers.<\/span>\r\n<span style=\"font-size: 14pt;\">Furthermore, we have a wide range of achievements, including building systems utilizing SAS and developing marketing analysis systems. Through our alliance partner agreement with SAS Institute Japan, Ltd. (SAS) and our quality management system, which includes ISO9001 certification, we provide high-value-added services to pharmaceutical companies, CROs, and academia.<\/span>\r\n<span style=\"font-size: 14pt;\">Going forward, Japan Media Co., Ltd. will continue to leverage its unique strengths to address various challenges in drug development and contribute to the overall advancement of the industry.<\/span>\r\n\r\n&nbsp;\r\n\r\n&nbsp;\r\n<h3><span style=\"font-size: 14pt;\">About Aspark Medical, Inc.<\/span><\/h3>\r\n<span style=\"font-size: 14pt;\">Aspark Medical is a hybrid CRO capable of supporting pharmaceutical companies from clinical development to PMS on both a staffing and contract basis.<\/span>\r\n<span style=\"font-size: 14pt;\">Starting from aspark's medical division, we have achieved over 60 clients in the roughly 20 years since our spin-off and establishment as an independent company.<\/span>\r\n<span style=\"font-size: 14pt;\">Even now, with 100 mid-career hires before welcoming new graduates in April 2023, we remain a company that has brought together professionals with diverse backgrounds and experiences%, including those from pharmaceutical companies and CROs. We still retain our venture spirit and can offer proposals for staffing, contract services, and BPO tailored to our clients' needs.<\/span>","protected":false},"excerpt":{"rendered":"<p>\u65e5\u672c\u30e1\u30c7\u30a3\u30a2\u682a\u5f0f\u4f1a\u793e\uff08\u672c\u793e\uff1a\u5927\u962a\u5e9c\u5927\u962a\u5e02\u3001\u4ee3\u8868\u53d6\u7de0\u5f79\uff1a\u5317\u672c \u4eae\u4e8c\uff09\u306f\u3001\u4eba\u6750\u6d3e\u9063\u53ca\u3073\u533b\u85ac\u54c1\u958b\u767a\u652f\u63f4\u306e\u682a\u5f0f\u4f1a\u793e\u30a2\u30b9\u30d1\u30fc\u30af\u30e1\u30c7\u30a3\u30ab\u30eb\uff08\u672c\u793e\uff1a\u5927\u962a\u5e9c\u5927\u962a\u5e02\u3001\u4ee3\u8868\u53d6\u7de0\u5f79\uff1a\u8218\u5185 \u6052\u5f66\uff09\u3068\u53d7\u8a17\u8a66\u9a13\u306e\u52a0\u901f\u5316\u3092\u76ee\u6307\u3057\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u696d\u52d9 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"_links":{"self":[{"href":"https:\/\/www.japanmedia.co.jp\/en\/wp-json\/wp\/v2\/posts\/2413"}],"collection":[{"href":"https:\/\/www.japanmedia.co.jp\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.japanmedia.co.jp\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.japanmedia.co.jp\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.japanmedia.co.jp\/en\/wp-json\/wp\/v2\/comments?post=2413"}],"version-history":[{"count":30,"href":"https:\/\/www.japanmedia.co.jp\/en\/wp-json\/wp\/v2\/posts\/2413\/revisions"}],"predecessor-version":[{"id":2443,"href":"https:\/\/www.japanmedia.co.jp\/en\/wp-json\/wp\/v2\/posts\/2413\/revisions\/2443"}],"wp:attachment":[{"href":"https:\/\/www.japanmedia.co.jp\/en\/wp-json\/wp\/v2\/media?parent=2413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.japanmedia.co.jp\/en\/wp-json\/wp\/v2\/categories?post=2413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}